Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

All Programs
September 20, 2009
Nature Biotechnology

CGEMS researchers announce discovery of new area on chromosome 8 that is associated with risk for prostate cancer.

MGC
September 18, 2009
Genome Research

The MGC Project Team announces the completion of the Mammalian Gene Collection.

TARGET
June 09, 2009
Proceedings of the National Academy of Sciences

Researchers identified a poor prognostic subgroup of pediatric BCR-ABL1-negative ALL patients and reported that the JAK-mutated cases had a gene expression signature similar to BCR-ABL1 pediatric ALL and suggested inhibition of JAK signaling as a target for therapeutic intervention.

All Programs
March 29, 2009
Nature Genetics

CGEMS Researchers have identified new genetic variations in two regions of DNA — located on chromosomes 1 and 14 — that may be associated with the risk of sporadic breast cancer.

TARGET
January 29, 2009
The New England Journal of Medicine

Scientists identified more than 50 recurring copy-number abnormalities in a cohort of patients with B-cell progenitor ALL. Abnormalities were found in genes that encode regulators of B-cell development, PAX5 and IKZF1, a gene that encodes the lymphoid transcription factor IKAROS.

TCGA
October 23, 2008
Nature

The Cancer Genome Atlas Research Network reported the first results of its large-scale, comprehensive study of the most common form of brain cancer, glioblastoma (GBM) in the advance online edition of the journal Nature, released September 4, 2008.

All Programs
February 10, 2008
Nature Genetics

The prostate cancer study looks at the association between multiple loci and the susceptibility to prostate cancer, which could be used as an indicator for high risk individuals (subscription required).

ICG
September 15, 2006
AACR Cancer Research

The Initiative for Chemical Genetics (ICG), created by NCI, enables public research using small molecules to accelerate the discovery of cancer-relevant small-molecule probes.

Pages

CSVXML